| Ident. | Authors (with country if any) | Title |
|---|
| 000001 (2020) |
J. Matías-Guiu ; U. Gomez-Pinedo ; P. Montero-Escribano ; P. Gomez-Iglesias ; J. Porta-Etessam ; J. A. Matias-Guiu | ¿Es esperable que haya cuadros neurológicos por la pandemia por SARS-CoV-2? |
| 000006 (2020) |
J. Reina [Espagne] | [Remdesivir, the antiviral hope against SARS-CoV-2]. |
| 000010 (2020) |
Peter Kranke ; Stephanie Weibel ; Magdalena Sitter ; Patrick Meybohm ; Thierry Girard | [Obstetric Anesthesia During the SARS-CoV-2 Pandemic - a Brief Overview of Published Recommendations for Action by National and International Specialist Societies and Committees]. |
| 000015 (2020) |
M. Liu [République populaire de Chine] ; R E Feng [République populaire de Chine] ; Q. Li [République populaire de Chine] ; H K Zhang [République populaire de Chine] ; Y G Wang [République populaire de Chine] | [Comparison of pathological changes and pathogenic mechanisms caused by H1N1 influenza virus, highly pathogenic H5N1 avian influenza virus, SARS-CoV, MERS-CoV and 2019-nCoV coronavirus]. |
| 000023 (2020) |
Thomas R. O'Brien [États-Unis] ; David L. Thomas [États-Unis] ; Sarah S. Jackson [États-Unis] ; Ludmila Prokunina-Olsson [États-Unis] ; Raymond P. Donnelly [États-Unis] ; Rune Hartmann [Danemark] | Weak Induction of Interferon Expression by SARS-CoV-2 Supports Clinical Trials of Interferon Lambda to Treat Early COVID-19. |
| 000027 (2020) |
Jaffar A. Al-Tawfiq [États-Unis] | Viral loads of SARS-CoV, MERS-CoV and SARS-CoV-2 in respiratory specimens: What have we learned? |
| 000040 (2020) |
Chang Hoon Yang ; Hyejin Jung | Topological dynamics of the 2015 South Korea MERS-CoV spread-on-contact networks |
| 000043 (2020) |
Jrhau Lung [Taïwan] ; Yu-Shih Lin [Taïwan] ; Yao-Hsu Yang [Taïwan] ; Yu-Lun Chou [Taïwan] ; Li-Hsin Shu [Taïwan] ; Yu-Ching Cheng [Taïwan] ; Hung Te Liu [Taïwan] ; Ching-Yuan Wu [Taïwan] | The potential chemical structure of anti-SARS-CoV-2 RNA-dependent RNA polymerase. |
| 000046 (2020) |
Yan-Chao Li [République populaire de Chine] ; Wan-Zhu Bai [République populaire de Chine] ; Tsutomu Hashikawa [Japon] | The neuroinvasive potential of SARS-CoV2 may play a role in the respiratory failure of COVID-19 patients. |
| 000049 (2020) |
Suliman Khan [République populaire de Chine] ; Rabeea Siddique [République populaire de Chine] ; Muhammad Adnan Shereen [République populaire de Chine] ; Ashaq Ali [République populaire de Chine] ; Jianbo Liu ; Qian Bai [République populaire de Chine] ; Nadia Bashir [République populaire de Chine] ; Mengzhou Xue [République populaire de Chine] | The emergence of a novel coronavirus (SARS-CoV-2), their biology and therapeutic options. |
| 000053 (2020) |
Maged Gomaa Hemida [Arabie saoudite] ; Mohammed M. Ba Abduallah [Arabie saoudite] | The SARS-CoV-2 outbreak from a one health perspective. |
| 000054 (2020) |
Wen-Hsiang Chen [États-Unis] ; Ulrich Strych [États-Unis] ; Peter J. Hotez [États-Unis] ; Maria Elena Bottazzi [États-Unis] | The SARS-CoV-2 Vaccine Pipeline: an Overview. |
| 000060 (2020) |
Yuxin Yan [République populaire de Chine] ; Woo In Shin [Malaisie] ; Yoong Xin Pang [République populaire de Chine] ; Yang Meng [République populaire de Chine] ; Jianchen Lai [République populaire de Chine] ; Chong You [République populaire de Chine] ; Haitao Zhao [États-Unis] ; Edward Lester [Royaume-Uni] ; Tao Wu [République populaire de Chine] ; Cheng Heng Pang [République populaire de Chine] | The First 75 Days of Novel Coronavirus (SARS-CoV-2) Outbreak: Recent Advances, Prevention, and Treatment. |
| 000062 (2020) |
Liang Chen [République populaire de Chine] ; Xiangjie Li [République populaire de Chine] ; Mingquan Chen [République populaire de Chine] ; Yi Feng [République populaire de Chine] ; Chenglong Xiong [République populaire de Chine] | The ACE2 expression in human heart indicates new potential mechanism of heart injury among patients infected with SARS-CoV-2. |
| 000068 (2020) |
Maryam Salamatbakhsh [Iran] ; Kazhal Mobaraki [Iran] ; Jamal Ahmadzadeh [Iran] | Syndromic Surveillance System for MERS-CoV as New Early Warning and Identification Approach |
| 000069 (2020) |
| Syndromic Surveillance System for MERS-CoV as New Early Warning and Identification Approach [Corrigendum] |
| 000073 (2020) |
Mushtaq Hussain [Pakistan] ; Nusrat Jabeen [Pakistan] ; Fozia Raza [Pakistan] ; Sanya Shabbir [Pakistan] ; Ayesha A. Baig [Pakistan] ; Anusha Amanullah [Pakistan] ; Basma Aziz [Pakistan] | Structural variations in human ACE2 may influence its binding with SARS-CoV-2 spike protein. |
| 000074 (2020) |
Muhammad Tahir Ul Qamar [République populaire de Chine] ; Safar M. Alqahtani [Arabie saoudite] ; Mubarak A. Alamri [Arabie saoudite] ; Ling-Ling Chen [République populaire de Chine] | Structural basis of SARS-CoV-2 3CLpro and anti-COVID-19 drug discovery from medicinal plants† |
| 000080 (2020) |
Kun Li [États-Unis] ; Zhuo Li [États-Unis] ; Christine Wohlford-Lenane [États-Unis] ; David K. Meyerholz [États-Unis] ; Rudragouda Channappanavar [États-Unis] ; Dong An [États-Unis] ; Stanley Perlman [États-Unis] ; Paul B. Mccray [États-Unis] ; Biao He [États-Unis] | Single-Dose, Intranasal Immunization with Recombinant Parainfluenza Virus 5 Expressing Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Spike Protein Protects Mice from Fatal MERS-CoV Infection |
| 000082 (2020) |
Gerard Kian-Meng Goh [Singapour] ; A. Keith Dunker [États-Unis] ; James A. Foster [États-Unis] ; Vladimir N. Uversky [États-Unis, Russie] | Shell disorder analysis predicts greater resilience of the SARS-CoV-2 (COVID-19) outside the body and in body fluids |
| 000085 (2020) |
Afnan A. Degnah [Arabie saoudite] ; Sawsan S. Al-Amri [Arabie saoudite] ; Ahmed M. Hassan [Arabie saoudite] ; Abdulrahman S. Almasoud [Arabie saoudite] ; Manar Mousa [Arabie saoudite] ; Sarah A. Almahboub [Arabie saoudite] ; Rowa Y. Alhabbab [Arabie saoudite] ; Ahmed A. Mirza [Arabie saoudite] ; Salwa I. Hindawi [Arabie saoudite] ; Naif Khalaf Alharbi [Arabie saoudite] ; Esam I. Azhar [Arabie saoudite] ; Anwar M. Hashem [Arabie saoudite] | Seroprevalence of MERS-CoV in healthy adults in western Saudi Arabia, 2011–2016 |
| 000087 (2020) |
Firas A. Rabi [Jordanie] ; Mazhar S. Al Zoubi [Jordanie] ; Ghena A. Kasasbeh [Jordanie] ; Dunia M. Salameh [Jordanie] ; Amjad D. Al-Nasser [Jordanie] | SARS-CoV-2 and Coronavirus Disease 2019: What We Know So Far. |
| 000088 (2020) |
Janko Nikolich-Zugich [États-Unis] ; Kenneth S. Knox [États-Unis] ; Carlos Tafich Rios [États-Unis] ; Bhupinder Natt [États-Unis] ; Deepta Bhattacharya [États-Unis] ; Mindy J. Fain [États-Unis] | SARS-CoV-2 and COVID-19 in older adults: what we may expect regarding pathogenesis, immune responses, and outcomes |
| 000089 (2020) |
D. Katterine Bonilla-Aldana | SARS-CoV, MERS-CoV and now the 2019-novel CoV: Have we investigated enough about coronaviruses? – A bibliometric analysis☆ |
| 000091 (2020) |
Abdo A. Elfiky | Ribavirin, Remdesivir, Sofosbuvir, Galidesivir, and Tenofovir against SARS-CoV-2 RNA dependent RNA polymerase (RdRp): A molecular docking study |
| 000097 (2020) |
Shuntong Kang [République populaire de Chine] ; Wenyao Peng [République populaire de Chine] ; Yuhao Zhu [République populaire de Chine] ; Shiyao Lu [République populaire de Chine] ; Min Zhou [République populaire de Chine] ; Wei Lin [République populaire de Chine] ; Wenfang Wu [République populaire de Chine] ; Shu Huang [République populaire de Chine] ; Liping Jiang [République populaire de Chine] ; Xuan Luo [République populaire de Chine] ; Meichun Deng [République populaire de Chine] | Recent progress in understanding 2019 novel coronavirus (SARS-CoV-2) associated with human respiratory disease: detection, mechanisms and treatment |
| 000103 (2020) |
Emmie De Wit ; Friederike Feldmann ; Jacqueline Cronin ; Robert Jordan ; Atsushi Okumura ; Tina Thomas ; Dana Scott ; Tomas Cihlar ; Heinz Feldmann | Prophylactic and therapeutic remdesivir (GS-5734) treatment in the rhesus macaque model of MERS-CoV infection |
| 000107 (2020) |
Syed Faraz Ahmed [République populaire de Chine] ; Ahmed A. Quadeer [République populaire de Chine] ; Matthew R. Mckay [République populaire de Chine] | Preliminary Identification of Potential Vaccine Targets for the COVID-19 Coronavirus (SARS-CoV-2) Based on SARS-CoV Immunological Studies. |
| 000111 (2020) |
David A. Schwartz [États-Unis] ; Ashley L. Graham | Potential Maternal and Infant Outcomes from Coronavirus 2019-nCoV (SARS-CoV-2) Infecting Pregnant Women: Lessons from SARS, MERS, and Other Human Coronavirus Infections |
| 000112 (2020) |
A Jin Cho [Corée du Sud] ; Hong-Seock Lee [Corée du Sud] ; Young-Ki Lee [Corée du Sud] ; Hee Jung Jeon [Corée du Sud] ; Hayne Cho Park [Corée du Sud] ; Da-Wun Jeong [Corée du Sud] ; Yang-Gyun Kim [Corée du Sud] ; Sang-Ho Lee [Corée du Sud] ; Chang-Hee Lee [Corée du Sud] ; Kyung Don Yoo [Corée du Sud] ; Ae Kyeong Wong [Corée du Sud] | Post-traumatic stress symptoms in hemodialysis patients with MERS-CoV exposure |
| 000120 (2020) |
F. Al Kindi ; S. Chandrasekhar Nair ; R. Hashmey | Pediatric Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Infection – UAE |
| 000123 (2020) |
Jia Liu [République populaire de Chine] ; Xin Zheng [République populaire de Chine] ; Qiaoxia Tong [République populaire de Chine] ; Wei Li [République populaire de Chine] ; Baoju Wang [République populaire de Chine] ; Kathrin Sutter [Allemagne] ; Mirko Trilling [Allemagne] ; Mengji Lu [Allemagne] ; Ulf Dittmer [Allemagne] ; Dongliang Yang [République populaire de Chine] | Overlapping and discrete aspects of the pathology and pathogenesis of the emerging human pathogenic coronaviruses SARS-CoV, MERS-CoV, and 2019-nCoV. |
| 000127 (2020) |
John S. Ji [République populaire de Chine] | Origins of MERS-CoV, and lessons for 2019-nCoV |
| 000128 (2020) |
M. Hemida | One Health-based control strategies for MERS-CoV |
| 000131 (2020) |
S A Meo [Arabie saoudite] ; A M Alhowikan ; T. Al-Khlaiwi ; I M Meo ; D M Halepoto ; M. Iqbal ; A M Usmani ; W. Hajjar ; N. Ahmed | Novel coronavirus 2019-nCoV: prevalence, biological and clinical characteristics comparison with SARS-CoV and MERS-CoV. |
| 000133 (2020) |
A L Giwa [États-Unis] ; Akash Desai [États-Unis] ; Andrea Duca [Italie] | Novel 2019 coronavirus SARS-CoV-2 (COVID-19): An updated overview for emergency clinicians |
| 000135 (2020) |
Shibo Jiang [République populaire de Chine] ; Christopher Hillyer [États-Unis] ; Lanying Du [États-Unis] | Neutralizing Antibodies against SARS-CoV-2 and Other Human Coronaviruses. |
| 000146 (2020) |
Hamid Y. Hussain [Émirats arabes unis, Iraq] | Middle East respiratory syndrome coronavirus (MERS-CoV): threats, gaps and containment strategies |
| 000147 (2020) |
Hamzah Z. Farooq [Royaume-Uni] ; Emma Davies [Royaume-Uni] ; Shazaad Ahmad [Royaume-Uni] ; Nicholas Machin [Royaume-Uni] ; Louise Hesketh [Royaume-Uni] ; Malcolm Guiver [Royaume-Uni] ; Andrew J. Turner [Royaume-Uni] | Middle East respiratory syndrome coronavirus (MERS-CoV) — Surveillance and testing in North England from 2012 to 2019 |
| 000149 (2020) |
Abdulkarim Al-Rabiaah [Arabie saoudite] ; Mohamad-Hani Temsah [Arabie saoudite] ; Ayman A. Al-Eyadhy [Arabie saoudite] ; Gamal M. Hasan [Arabie saoudite, Égypte] ; Fahad Al-Zamil [Arabie saoudite] ; Sarah Al-Subaie [Arabie saoudite] ; Fahad Alsohime [Arabie saoudite] ; Amr Jamal [Arabie saoudite] ; Ali Alhaboob [Arabie saoudite] ; Basma Al-Saadi [Arabie saoudite] ; Ali Mohammed Somily [Arabie saoudite] | Middle East Respiratory Syndrome-Corona Virus (MERS-CoV) associated stress among medical students at a university teaching hospital in Saudi Arabia |
| 000153 (2020) |
Jaffar A. Al-Tawfiq | Middle East Respiratory Syndrome Coronavirus (MERS-CoV) and COVID-19 infection during pregnancy |
| 000154 (2020) |
Alice N. Kiyong'A [Kenya] ; Elizabeth A J. Cook [Kenya] ; Nisreen M A. Okba [Pays-Bas] ; Velma Kivali [Kenya] ; Chantal Reusken [Pays-Bas] ; Bart L. Haagmans [Pays-Bas] ; Eric M. Fèvre [Kenya] | Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Seropositive Camel Handlers in Kenya. |
| 000158 (2020) |
B. Alosaimi ; M. Awadalla ; M. Enani | MERS-CoV infection is associated with downregulation of genes encoding Th1 and Th2 cytokines/chemokines and elevated inflammatory innate immune response in the lower respiratory tract |
| 000162 (2020) |
Ying Yan [République populaire de Chine] ; Le Chang [République populaire de Chine] ; Lunan Wang [République populaire de Chine] | Laboratory testing of SARS-CoV, MERS-CoV, and SARS-CoV-2 (2019-nCoV): Current status, challenges, and countermeasures. |
| 000166 (2020) |
Yushim Kim [États-Unis] ; Seong Soo Oh [Corée du Sud] ; Minyoung Ku [États-Unis] ; Jihyun Byeon [Corée du Sud] | Interorganizational Coordination and Collaboration During the 2015 MERS-CoV Response in South Korea. |
| 000167 (2020) |
Hossam M. Ashour [États-Unis] ; Walid F. Elkhatib [Égypte] ; Md Masudur Rahman [Bangladesh] ; Hatem A. Elshabrawy [États-Unis] | Insights into the Recent 2019 Novel Coronavirus (SARS-CoV-2) in Light of Past Human Coronavirus Outbreaks. |
| 000168 (2020) |
Mingxuan Xie [République populaire de Chine] ; Qiong Chen [République populaire de Chine] | Insight into 2019 novel coronavirus — an updated intrim review and lessons from SARS-CoV and MERS-CoV |
| 000170 (2020) |
Shuai Xia [République populaire de Chine] ; Meiqin Liu [République populaire de Chine] ; Chao Wang [République populaire de Chine] ; Wei Xu [République populaire de Chine] ; Qiaoshuai Lan [République populaire de Chine] ; Siliang Feng [République populaire de Chine] ; Feifei Qi [République populaire de Chine] ; Linlin Bao [République populaire de Chine] ; Lanying Du [États-Unis] ; Shuwen Liu [République populaire de Chine] ; Chuan Qin [République populaire de Chine] ; Fei Sun [République populaire de Chine] ; Zhengli Shi [République populaire de Chine] ; Yun Zhu [République populaire de Chine] ; Shibo Jiang [République populaire de Chine, États-Unis] ; Lu Lu [République populaire de Chine] | Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion |
| 000172 (2020) |
Won Mo Jang [Corée du Sud] ; Un-Na Kim [Corée du Sud] ; Deok Hyun Jang [Corée du Sud] ; Hyemin Jung [Corée du Sud] ; Sanghyun Cho [Corée du Sud] ; Sang Jun Eun [Corée du Sud] ; Jin Yong Lee [Corée du Sud] | Influence of trust on two different risk perceptions as an affective and cognitive dimension during Middle East respiratory syndrome coronavirus (MERS-CoV) outbreak in South Korea: serial cross-sectional surveys |
| 000179 (2020) |
Mohsen Rokni [Iran] ; Vida Ghasemi [Iran] ; Zahra Tavakoli [Iran] | Immune responses and pathogenesis of SARS-CoV-2 during an outbreak in Iran: Comparison with SARS and MERS. |
| 000186 (2020) |
Ling Lin [République populaire de Chine] ; Lianfeng Lu [République populaire de Chine] ; Wei Cao [République populaire de Chine] ; Taisheng Li [République populaire de Chine] | Hypothesis for potential pathogenesis of SARS-CoV-2 infection-a review of immune changes in patients with viral pneumonia. |
